Enhanced oral bioavailability of dexibuprofen by a novel solid Self-emulsifying drug delivery system (SEDDS)

Bonabello, 2003, Dexibuprofen (S(+)-isomer ibuprofen) reduces gastric damage and improves analgesic and anti-inflammatory effects in rodents, Anaesth. Analg., 97, 402, 10.1213/01.ANE.0000073349.04610.42

Cox, 1999, Development and evaluation of a multiple-unit oral sustained release dosage form for S(+)-ibuprofen: preparation and release kinetics, Int. J. Pharm., 193, 73, 10.1016/S0378-5173(99)00320-8

Kaehler, 2003, Dexibuprofen: pharmacology, therapeutic uses and safety, Inflammopharmacology, 11, 371, 10.1163/156856003322699555

Kachrimanis, 2000, Spherical crystal agglomeration of ibuprofen by the solvent-change technique in presence of methacrylic polymers, J. Pharm. Sci., 89, 250, 10.1002/(SICI)1520-6017(200002)89:2<250::AID-JPS12>3.0.CO;2-W

Yong, 2005, Enhanced oral bioavailability of ibuprofen in rats by poloxamer gel using poloxamer 188 and menthol, Drug Dev. Ind. Pharm., 31, 615, 10.1080/03639040500216113

Li, 2008, Novel gelatin microcapsule with bioavailability enhancement of ibuprofen using spray-drying technique, Int. J. Pharm., 355, 277, 10.1016/j.ijpharm.2007.12.020

Cui, 2008, Preparation and evaluation of self-microemulsifying drug delivery system containing Vinpocetine, Biol. Pharm. Bull., 31, 118, 10.1248/bpb.31.118

Chi, 1999, Enhanced dissolution rate of biphenyl dimethyl dicarboxylate using SMEDDS, B.T. Gattefosse., 92, 75

Woo, 2008, Reduced food-effect and enhanced bioavailability of a self-microemulsifying formulation of itraconazole in healthy volunteers, Eur. J. Pharm. Biopharm., 33, 159

Wilson, 1997, The behavior of fats and oils in the upper G.I. Tract, B.T. Gattefosse, 90, 13

I. Kovacs, M. Jusztin, E. Takacs, Z. Balazs, I. Kiss, Z. Varga, S. Jancso, C. Heim, I.K. Korcsmavos, E. Erdohati, M. Jarabin, US Patent, No. 5 583 105, 1996.

Chen, 2008, Self-Microemulsifying Drug Delivery System (SMEDDS) of Vinpocetine: formulation development and in vivo assessment, Biol. Pharm. Bull., 1, 118, 10.1248/bpb.31.118

Tuleu, 2004, Comparative bioavailability study in dogs of a self-emulsifying formulation of progesterone presented in a pellet and liquid form compared with an aqueous suspension of progesterone, J. Pharm. Sci., 93, 1495, 10.1002/jps.20068

Nazzal, 2006, Controlled release of a self-emulsifying formulation from a tablet dosage form: stability assessment and optimization of some processing parameters, Int. J. Pharm., 315, 110, 10.1016/j.ijpharm.2006.02.019

Franceschinis, 2005, Self-emulsifying pellets prepared by wet granulation in high-shear mixer: influence of formulation variables and preliminary study on the in vitro absorption, Int. J. Pharm., 291, 87, 10.1016/j.ijpharm.2004.07.046

Yi, 2008, A new solid self-micro emulsifying formulation prepared by spray-drying to improve the oral bioavailability of poorly water soluble drugs, Eur. J. Pharm. Biopharm., 70, 439, 10.1016/j.ejpb.2008.05.001

Craig, 1995, An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopy, Int. J. Pharm., 114, 103, 10.1016/0378-5173(94)00222-Q

Society of Toxicology (SOT), Guilding Priciples in the Use of Animals in Toxicology, 1999. Available from: <http://www.toxicology.org/AI/FA/guidingprinciples.pdf/>.

Prasad, 2003, Enhanced intestinal absorption of vancomycin with Labrasol and d-α-tocopheryl PEG 1000 succinate in rats, Int. J. Pharm., 250, 181, 10.1016/S0378-5173(02)00544-6

Kang, 2004, Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs, Int. J. Pharm., 274, 65, 10.1016/j.ijpharm.2003.12.028

Pouton, 2000, Lipid formulations for oral administration of drugs: nonemulsifying, self-emulsifying and self-microemulsifying drug delivery systems, Eur. J. Pharm. Sci., 11, S93, 10.1016/S0928-0987(00)00167-6

Shah, 1994, Self- emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs, Int. J. Pharm., 106, 15, 10.1016/0378-5173(94)90271-2

Constanitinides, 1994, Formulation and intestinal absorption enhancement evaluation of water-in-oil microemulsion incorporating medium-chain glycerides, Pharm. Res., 11, 1385, 10.1023/A:1018927402875

Walser, 1997, Preliminary toxicokinetic study with different crystal forms of S (+)-ibuprofen (dexibuprofen) and RS-ibuprofen in rats, Arzneimittelforschung, 47, 750

Takeuchi, 2005, Solid dispersion particles of amorphous indomethacin with fine porous silica particles by using spray-drying method, Int. J. Pharm., 293, 155, 10.1016/j.ijpharm.2004.12.019

M.J. Jackson, Drug transport across gastrointestinal epithelial, in: Physiology of the Gastrointestinal Tract, Raven Press, New York, 1987, pp. 1597–1621.

Swenson, 1992, Means to enhance penetration, Adv. Drug. Deliv. Rev., 8, 39, 10.1016/0169-409X(92)90015-I

Lindmark, 1995, Mechanisms of absorption enhancement by medium chain fatty acids in intestinal epithelial Caco-2 monolayers, J. Pharmacol. Exp. Ther., 275, 958